FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/05/019344 [Registered on: 24/05/2019] Trial Registered Prospectively
Last Modified On: 17/11/2019
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Follow Up Study 
Study Design  Single Arm Study 
Public Title of Study   Does the location and length of blockage in arteries of heart matter 
Scientific Title of Study   Impact of location and length of intermediate coronary stenosis on its physiological significance using fractional flow reserve and its correlation with intravascular ultrasound. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  JEET RAM KASHYAP 
Designation  ASSOCIATE PROFESSOR 
Affiliation  Government Medical College & Hospital, Sector-32, Chandigarh, INDIA 
Address  DEPARTMENT OF CARDIOLOGY GOVERNMENT MEDICAL COLLEGE CHANDIGARH

Chandigarh
CHANDIGARH
160030
India 
Phone  9646461971  
Fax    
Email  jeetramkashyap@yahoo.com  
 
Details of Contact Person
Scientific Query
 
Name  JEET RAM KASHYAP 
Designation  ASSOCIATE PROFESSOR 
Affiliation  Government Medical College & Hospital, Sector-32, Chandigarh, INDIA 
Address  DEPARTMENT OF CARDIOLOGY GMCH 32 CHANDIGARH

Chandigarh
CHANDIGARH
160030
India 
Phone  9646461971  
Fax    
Email  jeetramkashyap@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  JEET RAM KASHYAP 
Designation  ASSOCIATE PROFESSOR 
Affiliation  Government Medical College & Hospital, Sector-32, Chandigarh, INDIA 
Address  DEPARTMENT OF CARDIOLOGY GMCH 32 CHANDIGARH

Chandigarh
CHANDIGARH
160030
India 
Phone  9646461971  
Fax    
Email  jeetramkashyap@yahoo.com  
 
Source of Monetary or Material Support  
GOVERNMENT MEDICAL COLLEGE & HOSPITAL SECTOR 32 B CHANDIGARH INDIA 
 
Primary Sponsor  
Name  GOVERNMENT MEDICAL COLLEGE HOSPITAL CHANDIGARH 
Address  SECTOR 32 B CHANDIGARH INDIA 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL   
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR JEET RAM KASHYAP  DEPARTMENT OF CARDIOLOGY GOVERNMENT MEDICAL COLLEGE & HOSPITAL CHANDIGARH  Room No 538 Block D Level 5 GMCH SECTOR 32 B CHANDIGARH
Chandigarh
CHANDIGARH 
09646461971

jeetramkashyap@yahoo.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE GOVERNMENT MEDICAL COLLEGE & HOSPITAL SECTOR 32 CHANDIGARH INDIA  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: I208||Other forms of angina pectoris,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  --  -- 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  90.00 Year(s)
Gender  Both 
Details  ALL PATIENTS AGED MORE THAN 18 YEARS WITH STABLE ANGINA WILLING TO PARTICIPATE IN THE STUDY AND HAVING INDICATIONS FOR CORONARY ANGIOGRAPHY AND HAVING INTERMEDIATE CORONARY STENOSIS ON ANGIOGRAPHY e.i. 40 - 80% SHALL BE INCLUDED IN THE STUDY FOR FUTHER EVALUATION OF THESE LESIONS BY USING FRACTIONAL FLOW RESERVE FFR TO KNOW THEIR PHYSIOLOGICAL SIGNIFICANCE AND INTRAVASCULAR ULTRASOUND SHALL ALSO BE DONE TO KNOW THE PLAQUE MORPHOLOGY AND COMPOSITION TO FINF THE CORRELATION BETWEEN FFR AND IVUS AS WELL AS QCA. 
 
ExclusionCriteria 
Details  1. Acute coronary syndrome (STEMI/NSTEMI/UA)
2. Culprit lesion of previous myocardial infarction
3. Previous coronary artery bypass surgery
4. Tandem lesion
5. In-stent restenosis lesion
6. Cardiogenic shock
7. Low left ventricular systolic function (LVEF < 40%)
8. Chronic Kidney Disease
9. Chronic Liver Disease
10. Pregnant females
11. Failure to obtain informed consent from participants
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
CORRELATION BETWEEN LOCATION AND LENGTH OF LESION ON ITS PHYSIOLOGICAL SIGNIFICANCE BY USING FRACTIONAL FLOW RESERVE (FFR)  At 1 year 
 
Secondary Outcome  
Outcome  TimePoints 
1. To determine the correlation between QCA, IVUS and FFR for intermediate coronary lesions.
2. To find a correlation between FFR and BARI scores used for assessment of myocardial area under jeopardy
 
CROSS SECTIONAL  
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/06/2019 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   NOT YET STARTED 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   THIS STUDY SHALL BE CONDUCTED AT A SINGLE CENTRE IN NORTHERN PART OF INDIA e.i. GOVERNMENT MEDICAL COLLEGE & HOSPITAL SECTOR 32 CHANDIGARH IN PATIENTS WITH CHRONIC STABLE ANGINA AGED MORE THAN 18 YEARS AND HAVING INDICATIONS FOR CORONARY ANGIOGRAPHY AFTER OBTAINING INFORMED CONSENT.  THOSE PATIENT WHO SRE FOUND TO HAVE INTERMEDIATE CORONARY LESION SHALL FURTHER BE SUBJECTED TO FRACTIONAL FLOW RESERVE AND INTRAVASCULAR ULTRASOUND AND QCA ANALYSIS AND BARI SCORE EVALUATION. THE TRIAL PROTOCOL HAS BEEN ALREADY EVALUATED AND APPROVED BY THE RESEARCH COMMITTEE OF THE INSTITUTE AND HAS FURTHER BEEN SUBMITTED TO INSTITUTIONAL ETHICS COMMITTEE FOR FINAL APPROVAL. THE APPROVAL OF ETHICS COMMITTEE IS AVAITED VERY SOON AND THE DAY WE GET THE APPROVAL THE STUDY SHALL BE STATRED IMMEDIATELY. 
Close